Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland. Show more

CHEMIN DES MINES, 9, GENEVA, SWITZERLAND, 1202, Geneva, 1202, USA

https://www.addextherapeutics.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

4.291M

52 Wk Range

$3.39 - $11.97

Previous Close

$3.61

Open

$3.67

Volume

14,165

Day Range

$3.39 - $3.80

Enterprise Value

3.962M

Cash

935.2K

Avg Qtr Burn

-765.8K

Insider Ownership

0.00%

Institutional Own.

0.01%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ADX71149 (mGlu2 PAM) Details Epilepsy	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Dipraglurant (mGlu5 NAM) Details Brain Injury Recovery (Post-Stroke And Traumatic Brain Injury)	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NTX-253 (Muscarinic M4 PAM) Details Schizophrenia	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Dipraglurant (mGlu5 NAM) Details Levodopa-induced dyskinesia associated with Parkinson’s disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Dipraglurant (mGlu5 NAM) Details Dystonia (Blepharospasm)	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.